Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company...
Biotech Stocks At 52-Week Highs - ANIK & CHE Rise With Q2 Results, ICUI, NBIX, RPRX
Anika Therapeutics turns to Q2 FY26 net income of 3.31 million; revenue rises 16% to 32.61 million
ANIK: Revenue up 16% year-over-year, gross margin at 65%, and FY 2026 guidance raised
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Anika Therap | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 32.61 M
Anika Reports Second Quarter 2026 Financial Results | ANIK Stock News